Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas.

Endocrine pathology - 1 Sept 2012

Kurt Bülent, Yalçın Serap, Alagöz Engin, Karslıoğlu Yıldırım, Yigit Nuri, Günal Armağan, Deveci M Salih

Abstract excerpt

It has been shown that BRAF(V600E) mutation in papillary thyroid carcinomas (PTC) is associated both with pathogenesis and poor prognosis. In this study, we aimed to investigate the relationship of the BRAF(V600E) mutation and the established prognostic factors in a cohort of Turkish patients wit...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Carcinoma, Papillary
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to Turkey

Source

Identifiers

PMID: 22767446
DOI: 10.1007/s12022-012-9218-7

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22767446-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas.PMID 22767446Read ↗

The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.Semantic proximity Read ↗

The relation between BRAFV600E mutation and clinicopathological characteristics of papillary thyroid cancer.Semantic proximity Read ↗

The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.Semantic proximity Read ↗

BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.Semantic proximity Read ↗

The association between BRAF (V600E) mutation and pathological features in PTC.Semantic proximity Read ↗

Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis.Semantic proximity Read ↗

[Correlation between BRAF V600E mutation and clinicopathologic features of papillary thyroid carcinoma].Semantic proximity Read ↗

Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature.Semantic proximity Read ↗

The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese PopulationSemantic proximity Read ↗

Response to therapy of papillary thyroid cancer of known BRAF status.Semantic proximity Read ↗

BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma.Semantic proximity Read ↗

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.